Journal Basic Info

  • Impact Factor: 1.995**
  • H-Index: 8
  • ISSN: 2474-1647
  • DOI: 10.25107/2474-1647
**Impact Factor calculated based on Google Scholar Citations. Please contact us for any more details.

Major Scope

  •  Neurological Surgery
  •  Urology
  •  Colon and Rectal Surgery
  •  Thoracic Surgery
  •  Oral and Maxillofacial Surgery
  •  Obstetrics Surgery
  •  Breast Surgery
  •  Cardiovascular Surgery


Citation: Clin Surg. 2021;6(1):3197.Research Article | Open Access

ECMO Cannulation Criteria in COVID-19 (ECC-VID) and Obesity: A Literature Review and Retrospective Cohort Analysis

Brian Hassani1*# , Christina Creel-Bulos1#, Michael Connor2 , Mark Caridi-Schieble1 , Casey Miller3 , Mani Danesmand3 and Jeffrey Jadvidfar3

Department of Anesthesiology, Emory Critical Care Center, Emory University School of Medicine, USA 2 Department of Medicine, Emory University School of Medicine, USA 3 Department of Surgery, Emory University School of Medicine, USA # Both authors contributed equally to this work

*Correspondance to: Brian Hassani 

 PDF  Full Text DOI: 10.25107/2474-1647.3197


Veno-Venous Extracorporeal Membrane Oxygenation (V-V ECMO) continues to be used as rescue therapy for patients with Acute Respiratory Distress Syndrome (ARDS) secondary to Coronavirus Disease 2019 (COVID-19). Although there is emerging literature on the use of and mortality associated with V-V ECMO in the management of patients with COVID-19, our understanding of who may benefit from this management strategy remains limited. Our clinicians sought to provide further insight into pre-cannulation characteristics and mortality in a cohort of patients with COVID-19 associated ARDS managed with V-V ECMO that primarily consisted of obese patients (90%, n=18) with a BMI of 30 kg/m2 or greater. Our findings not only revealed high survival to hospital discharge (70%, n=14), but demonstrated non-inferior outcomes and survival in obese patients. With an imminent next wave of rising infections, knowledge of which patients have a better chance of survival with the initiation of V-V ECMO is essential. Obese patients have been historically underrepresented in ECMO outcomes literature, but our findings suggest the utilization of ECMO for COVID-19 associated ARDS in these patient subsets should be considered and outcomes should be further explored.


V-V ECMO; COVID-19; Obesity; Critical care; Acute respiratory distress syndrome

Cite the article

Hassani B, Creel-Bulos C, Connor M, Caridi-Schieble M, Miller C, Danesmand M, et al. ECMO Cannulation Criteria in COVID-19 (ECC-VID) and Obesity: A Literature Review and Retrospective Cohort Analysis. Clin Surg. 2021; 6: 3197.

Search Our Journal

Journal Indexed In

Articles in PubMed

Antimicrobial Peptides: A Potential Therapeutic Option for Surgical Site Infections
 PubMed  PMC  PDF  Full Text
RAF Kinase Inhibitory Protein Expression and Phosphorylation Profiles in Oral Cancers
 PubMed  PMC  PDF  Full Text
View More...

Articles with Grants

Set Up New Cardiac Surgery Peri-Operative Service in a General Adult Intensive Care Unit during COVID-19 Pandemic
 Abstract  PDF  Full Text
PDGF/PDGFR Signaling in Cardiovascular Disease
 Abstract  PDF  Full Text
View More...